{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Others > Glycyrrhizic acid ammonium saltCAS：53956-04-0
Molecular Formula：C42H65NO16
Molecular Weight：839.96
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 53956-04-0 |
| Name | Glycyrrhizic acid ammonium salt |
| Molecular Formula | C42H65NO16 |
| Molecular Weight | 839.96 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 258-887-7 |
| MDL | MFCD00167400 |
| SMILES | O=C1[C@]([C@](CC2)(C)[C@@]3(C)C([C@]([C@@]4(C)CC3)([H])C[C@@](CC4)(C)C(O)=O)=C1)([H])[C@](CC5)(C)C2C([C@H]5O[C@@H](O[C@H](C([O-])=O)[C@H]6O)[C@H](O[C@@H]([C@H](O)[C@@H](O)[C@@H]7O)O[C@@H]7C(O)=O)[C@H]6O)(C)C.[NH4+] |
| InChIKey | ILRKKHJEINIICQ-OOFFSTKBSA-N |
| InChI | InChI=1S/C42H62O16.H3N/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50;/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54);1H3/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+;/m0./s1 |
| PubChem CID | 62074 |
| Target Point | Others |
| Passage | Others |
| Background | Glycyrrhizic acid ammonium salt has anti-inflammatory, anti-allergic, anti-gastric ulcer, anti-hepatitis and other pharmacological activities. |
| Biological Activity | Monoammonium glycyrrhizinate hydrate 具有抗炎、抗过敏、抗胃溃疡、抗肝炎等药理活性。[1-2] |
| Data Literature Source | [1]. Huang X，et al. Anti-Inflammatory Effects of Monoammonium Glycyrrhizinate on Lipopolysaccharide-Induced Acute Lung Injury in Mice through Regulating Nuclear Factor-Kappa B Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:272474. [2]. Zhou L，et al. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2，Ntcp，and Oatp1a4 in liver. Pharm Biol. 2016;54(6):931-7. |
| Unit | Bottle |
| Specification | 10mg 10mM*1mL in DMSO 20mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
